Evidence map›Paper›PMID 29749131›Full record

ArticleYonsei medical journal2018

The Impact of Prediabetes on Two-Year Clinical Outcomes in Patients Undergoing Elective Percutaneous Coronary Intervention.

Woong Gil Choi, Seung Woon Rha, Byoung Geol Choi, Se Yeon Choi, Jae Kyeong Byun, Ahmed Mashaly, Yoonjee Park, Won Young Jang, Woohyeun Kim, Jah Yeon Choi and 6 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in Yonsei medical journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Correlation between prediabetes and coronary artery disease severity in patients undergoing elective coronary angiography.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 2 countries.

Woong Gil ChoiCardiovascular Center, Korea University Guro Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0002-2235-8041
Seung Woon RhaCardiovascular Center, Korea University Guro Hospital, Seoul, Korea. swrha617@yahoo.co.kr.ORCID https://orcid.org/0000-0001-9456-9852
Byoung Geol ChoiCardiovascular Center, Korea University Guro Hospital, Seoul, Korea.
Se Yeon ChoiCardiovascular Center, Korea University Guro Hospital, Seoul, Korea.
Jae Kyeong ByunCardiovascular Center, Korea University Guro Hospital, Seoul, Korea.
Ahmed MashalyCardiovascular Center, Korea University Guro Hospital, Seoul, Korea.
Yoonjee ParkCardiovascular Center, Korea University Guro Hospital, Seoul, Korea.
Won Young JangCardiovascular Center, Korea University Guro Hospital, Seoul, Korea.
Woohyeun KimCardiovascular Center, Korea University Guro Hospital, Seoul, Korea.
Jah Yeon ChoiCardiovascular Center, Korea University Guro Hospital, Seoul, Korea.
Eun Jin ParkCardiovascular Center, Korea University Guro Hospital, Seoul, Korea.
Jin Oh NaCardiovascular Center, Korea University Guro Hospital, Seoul, Korea.
Cheol Ung ChoiCardiovascular Center, Korea University Guro Hospital, Seoul, Korea.
Eung Ju KimCardiovascular Center, Korea University Guro Hospital, Seoul, Korea.
Chang Gyu ParkCardiovascular Center, Korea University Guro Hospital, Seoul, Korea.
Hong Seog SeoCardiovascular Center, Korea University Guro Hospital, Seoul, Korea.
Korea University Medical Center · KRKonkuk University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePrediabetes is an independent risk factor for cardiovascular disease. However, data on the long term adverse clinical outcomes of prediabetic patients undergoing percutaneous coronary intervention (PCI) with drug-eluting stents (DESs) are scarce. MATERIALS AND

methodsThe study population comprised 674 consecutive non-diabetic patients who underwent elective PCI between April 2007 and November 2010. Prediabetes was defined as hemoglobin A1c (HbA1c) of 5.7% to 6.4%. Two-year cumulative clinical outcomes of prediabetic patients (HbA1c of 5.7% to 6.4%, n=242) were compared with those of a normoglycemic group (<5.7%, n=432).

resultsBaseline clinical and angiographic characteristics were similar between the two groups, except for higher glucose levels (104.8±51.27 mg/dL vs. 131.0±47.22 mg/dL, p<0.001) on admission in the prediabetes group. There was no significant difference between the two groups in coronary angiographic parameters, except for a higher incidence of diffuse long lesion in the prediabetes group. For prediabetic patients, trends toward higher incidences of binary restenosis (15.6% vs. 9.8 %, p=0.066) and late loss (0.71±0.70 mm vs. 0.59±0.62 mm, p=0.076) were noted. During the 24 months of follow up, the incidence of mortality in prediabetic patients was higher than that in normoglycemic patients (5.5% vs. 1.5%, p=0.007).

conclusionIn our study, a higher death rate and a trend toward a higher incidence of restenosis in patients with prediabetes up to 2 years, compared to those in normoglycemic patients, undergoing elective PCI with contemporary DESs.

Indexed as

Drug-Eluting StentsAgedBlood GlucoseCoronary AngiographyCoronary RestenosisElective Surgical ProceduresFemaleGlycated HemoglobinHumansIncidenceMiddle AgedPercutaneous Coronary InterventionPrediabetic StateRetrospective StudiesRisk FactorsSurvival RateBlood GlucoseGlycated Hemoglobindrug-eluting stentHemoglobin A1cpercutaneous coronary interventionprediabetes

Identifiers

PMID29749131
PMCPMC5949290
OpenAlexW2802485017

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.